tradingkey.logo

Cigna Group

CI

274.900USD

+3.970+1.46%
종가 08/08, 16:00ET시세는 15분 지연됩니다
73.29B시가총액
14.56P/E TTM

Cigna Group

274.900

+3.970+1.46%
자세한 내용은 Cigna Group 회사
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
회사 정보
종목 코드 CI
회사 이름Cigna Group
상장일Apr 01, 1982
CEOMr. David M. Cordani, CPA
직원 수73500
유형Ordinary Share
회계 연도 종료Apr 01
주소900 Cottage Grove Road
도시BLOOMFIELD
증권 거래소NYSE Consolidated
국가United States of America
우편 번호06002
전화18602266000
웹사이트https://www.thecignagroup.com/
종목 코드 CI
상장일Apr 01, 1982
CEOMr. David M. Cordani, CPA
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+16.47%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+20.32%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
수익 분석
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
사업별USD
이름
수익
비율
Pharmacy revenues
48.63B
0.00%
Network revenues
28.21B
0.00%
Home delivery and specialty revenues
18.94B
0.00%
Other revenues
3.08B
0.00%
Fees and other revenues
1.87B
0.00%
Intercompany eliminations
-1.61B
0.00%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Pharmacy revenues
48.63B
0.00%
Network revenues
28.21B
0.00%
Home delivery and specialty revenues
18.94B
0.00%
Other revenues
3.08B
0.00%
Fees and other revenues
1.87B
0.00%
Intercompany eliminations
-1.61B
0.00%
주식 보유 통계
마지막 업데이트: Thu, Aug 7
마지막 업데이트: Thu, Aug 7
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
4.97%
State Street Global Advisors (US)
4.67%
T. Rowe Price Associates, Inc.
4.37%
MFS Investment Management
4.28%
Other
71.97%
주주
주주
비율
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
4.97%
State Street Global Advisors (US)
4.67%
T. Rowe Price Associates, Inc.
4.37%
MFS Investment Management
4.28%
Other
71.97%
주주 유형
주주
비율
Investment Advisor
51.91%
Investment Advisor/Hedge Fund
29.82%
Research Firm
2.45%
Pension Fund
2.35%
Bank and Trust
1.79%
Hedge Fund
1.28%
Sovereign Wealth Fund
1.26%
Corporation
1.19%
Individual Investor
0.39%
Other
7.54%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
2945
245.93M
92.13%
-10.11M
2025Q1
2995
251.66M
94.16%
-8.16M
2024Q4
2993
255.45M
93.32%
-4.13M
2024Q3
2931
253.73M
90.72%
-10.03M
2024Q2
2910
254.99M
91.23%
-15.89M
2024Q1
2865
261.02M
89.38%
-14.30M
2023Q4
2815
267.28M
91.36%
-8.83M
2023Q3
2725
267.63M
91.08%
-13.20M
2023Q2
2737
270.13M
91.28%
-8.82M
2023Q1
2710
268.83M
90.70%
-14.56M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
26.02M
9.74%
+45.08K
+0.17%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.26M
4.97%
-120.53K
-0.90%
Mar 31, 2025
State Street Global Advisors (US)
12.47M
4.67%
-249.53K
-1.96%
Mar 31, 2025
T. Rowe Price Associates, Inc.
11.65M
4.36%
+1.09M
+10.30%
Mar 31, 2025
MFS Investment Management
11.31M
4.23%
+82.46K
+0.73%
Mar 31, 2025
Fidelity Management & Research Company LLC
10.52M
3.94%
+544.14K
+5.45%
Mar 31, 2025
Dodge & Cox
8.89M
3.33%
+117.13K
+1.34%
Mar 31, 2025
Sanders Capital, LLC
7.99M
2.99%
-65.52K
-0.81%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.04M
2.26%
+79.50K
+1.33%
Mar 31, 2025
GQG Partners, LLC
4.89M
1.83%
+865.09K
+21.51%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Wed, Aug 6
마지막 업데이트: Wed, Aug 6
이름
비율
iShares U.S. Healthcare Providers ETF
3.99%
VictoryShares Free Cash Flow ETF
3.94%
Invesco Dynamic Buyback Achievers ETF
3.83%
Monarch Dividend Plus Index ETF
2.86%
Fidelity Blue Chip Value ETF
2.75%
VictoryShares US Multi-Factor Minimum Vol ETF
2.59%
Brandes US Value ETF
2.27%
Davis Select US Equity ETF
2.21%
First Trust Health Care Alphadex Fund
2.19%
Bushido Capital US Equity ETF
2.16%
더 보기
iShares U.S. Healthcare Providers ETF
비율3.99%
VictoryShares Free Cash Flow ETF
비율3.94%
Invesco Dynamic Buyback Achievers ETF
비율3.83%
Monarch Dividend Plus Index ETF
비율2.86%
Fidelity Blue Chip Value ETF
비율2.75%
VictoryShares US Multi-Factor Minimum Vol ETF
비율2.59%
Brandes US Value ETF
비율2.27%
Davis Select US Equity ETF
비율2.21%
First Trust Health Care Alphadex Fund
비율2.19%
Bushido Capital US Equity ETF
비율2.16%
주식 배당금
지난 5년 동안 총 5.74B USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option
Sep 06, 2023
Sep 21, 2023
Sep 05, 2023
Apr 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option
Jun 07, 2023
Jun 22, 2023
Jun 06, 2023
Feb 03, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option
Mar 08, 2023
Mar 23, 2023
Mar 07, 2023
Oct 26, 2022
CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022
Dec 06, 2022
Dec 21, 2022
Dec 05, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
tradingkey.logo
tradingkey.logo
당일 거래 데이터는 Refinitiv에서 제공하며, 이용 약관이 적용됩니다. 역사적 및 현재 종가 데이터는 Refinitiv에서 제공합니다. 모든 시세는 현지 거래소 시간 기준입니다. 미국 주식 시세의 실시간 마지막 거래 데이터는 Nasdaq을 통해 보고된 거래만 반영됩니다. 당일 거래 데이터는 최소 15분 지연되거나 거래소 요구 사항에 따라 다를 수 있습니다.
* 참고자료, 분석 및 트레이딩 전략은 제3자 제공업체인 Trading Central에서 제공하며, 분석가의 독립적인 평가와 판단에 기반한 시각으로, 투자자의 투자 목표와 재정 상황은 고려되지 않습니다.
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유
KeyAI